Atlas Trials

An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia

Clinical trial NCT02077361 · COMPLETED

Trial details

NCT number
NCT02077361
Sponsor
University of Alberta
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Choroideremia
Start date
2015-04-01
Primary completion
2017-08-30
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.